These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29098384)

  • 21. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic resection for colorectal metastases: analysis of prognostic factors.
    Ambiru S; Miyazaki M; Isono T; Ito H; Nakagawa K; Shimizu H; Kusashio K; Furuya S; Nakajima N
    Dis Colon Rectum; 1999 May; 42(5):632-9. PubMed ID: 10344686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
    Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
    Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.
    Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J
    Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
    Blazer DG; Kishi Y; Maru DM; Kopetz S; Chun YS; Overman MJ; Fogelman D; Eng C; Chang DZ; Wang H; Zorzi D; Ribero D; Ellis LM; Glover KY; Wolff RA; Curley SA; Abdalla EK; Vauthey JN
    J Clin Oncol; 2008 Nov; 26(33):5344-51. PubMed ID: 18936472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
    Falcão D; Alexandrino H; Caetano Oliveira R; Martins J; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Cipriano MA; Castro E Sousa F
    Eur J Surg Oncol; 2018 Aug; 44(8):1212-1219. PubMed ID: 29691114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule.
    Hamady ZZ; Cameron IC; Wyatt J; Prasad RK; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2006 Jun; 32(5):557-63. PubMed ID: 16580811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
    Tanaka K; Nojiri K; Kumamoto T; Takeda K; Endo I
    Eur J Surg Oncol; 2011 Apr; 37(4):336-43. PubMed ID: 21277151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections.
    Figueras J; Burdio F; Ramos E; Torras J; Llado L; Lopez-Ben S; Codina-Barreras A; Mojal S
    Ann Oncol; 2007 Jul; 18(7):1190-5. PubMed ID: 17434896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making.
    Welsh FK; Tekkis PP; O'Rourke T; John TG; Rees M
    Surg Oncol; 2008 Jul; 17(1):3-13. PubMed ID: 18222689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy.
    Nikfarjam M; Shereef S; Kimchi ET; Gusani NJ; Jiang Y; Avella DM; Mahraj RP; Staveley-O'Carroll KF
    Ann Surg Oncol; 2009 Jul; 16(7):1860-7. PubMed ID: 19037703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
    Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
    Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival.
    Angelsen JH; Horn A; Eide GE; Viste A
    World J Surg Oncol; 2014 Apr; 12():127. PubMed ID: 24767422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
    Tranchart H; Chirica M; Faron M; Balladur P; Lefevre LB; Svrcek M; de Gramont A; Tiret E; Paye F
    World J Surg; 2013 Nov; 37(11):2647-54. PubMed ID: 23982776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
    Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?
    Adam R; de Haas RJ; Wicherts DA; Aloia TA; Delvart V; Azoulay D; Bismuth H; Castaing D
    J Clin Oncol; 2008 Aug; 26(22):3672-80. PubMed ID: 18669451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.